Status:
UNKNOWN
Maastricht IBS Cohort
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-75 years
Brief Summary
To set up a cohort of at least 400 IBS patients in order to identify different patient subgroups according to phenotypical and genotypical patterns and To set up a biobank for future translational st...
Detailed Description
Aim of the present study is to set up a large cohort of IBS patients in order to identify different disease characteristics as well as aetiological and pathophysiological factors in (sub)groups of pat...
Eligibility Criteria
Inclusion
- IBS-patients
Exclusion
- Severe co-morbidity hindering a rectal barostat procedure, according to the gastroenterologist's perception.
- Abdominal surgery, except for uncomplicated appendectomy, laparoscopic cholecystectomy or hysterectomy.
- Inability to stop medication that can influence gastrointestinal motility or perception (like loperamide, butylscopolamine, psylliumsead (metamucil), duspatal, metoclopramide, domperidon, erytromycin and serotonin reuptake inhibitors), for at least 3 days before tests.
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00775060
Start Date
September 1 2009
End Date
September 1 2024
Last Update
April 7 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Medical Center
Maastricht, Netherlands